Free shipping on all orders over $ 500

WZB117

Cat. No. M6156

All AbMole products are for research use only, cannot be used for human consumption.

WZB117  Structure
Size Price Availability Quantity
1mg USD 30 In stock
5mg USD 54 In stock
10mg USD 82 In stock
25mg USD 145 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

In vitro: WZB117 inhibits glucose transport in human red blood cells. Cancer cell treatment with WZB117 leads to decreases in levels of Glut1 protein, intracellular ATP, and glycolytic enzymes. All these changes are followed by increase in ATP-sensing enzyme AMP-activated protein kinase (AMPK) and declines in cyclin E2 as well as phosphorylated retinoblastoma, resulting in cell-cycle arrest, senescence, and necrosis.

In vivo: Daily intraperitoneal injection of WZB117 at 10mg/kg resultes in 70% reduction in tumor volume of human A549 lung cancer grafted on nude mice.

Protocol (for reference only)
Cell Experiment
Cell lines Human non–small cell lung cancer (NSCLC) cell
Preparation method Cells were treated with compound WZB117 for 24 or 48 hours. WZB117 (10 μmol/L) was used in the experiments unless otherwise noted.
Concentrations 10 μmol/L
Incubation time 24 or 48 h
Animal Experiment
Animal models BALB/cAJcl-nu/nu mice
Formulation DMSO
Dosages 3.6 mL/kg/day
Administration i.v.
Chemical Information
Molecular Weight 368.31
Formula C20H13FO6
CAS Number 1223397-11-2
Solubility (25°C) 63 mg/mL in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Shibuya K, et al. Oncotarget. Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.

[2] Liu Y, et al. Mol Cancer Ther. A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.

Related GLUT Products
STF-31

STF-31 is a selective glucose transporter GLUT1 inhibitor, with an IC50 of 1 μM. STF-31 is also a NAMPT inhibitor.

1,9-Dideoxyforskolin

1,9-Dideoxyforskolin is a inactive analog of forskolin

Dihydrokainic acid

Dihydrokainic acid is a selective inhibitor of the GLT-1 glutamate transporter.

BAY-876

BAY-876 is a potent, highly selective, cell-permeable inhibitor of glucose transporter GLUT1 with an IC50 of 2 nM. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth. BAY-876 can induce the formation of disulfide bonds in actin cytoskeletal proteins, leading to the occurrence of cellular disulfidptosis.

BAY-588

BAY-588 is an inactive control probe for BAY-876.

  Catalog
Abmole Inhibitor Catalog




Keywords: WZB117 supplier, GLUT, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.